At a glance
ClinicalIndex Comparison RecordN/ACompleted· 452 enrolled
Drug / intervention
Observationalother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
In Brief
An observational study evaluating Observational for Cystic Fibrosis. Completed, enrolled 452 participants across 38 sites.
Detailed Summary
identify and validate biomarkers that might reflect partial restoration of CFTR function and can be used to monitor disease progression, and ii) evaluate the mechanistic effects of CFTR modulators and other relevant therapies in individuals with CF
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis
CountriesUnited States
CollaboratorsCystic Fibrosis Foundation
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartMar 2015
First PostedJun 2015
Primary CompletionApr 2018
Study CompletionJul 2018
TodayJul 2026
First PostedJun 22, 2015
Enrollment StartMar 1, 2015
Primary CompletionApr 25, 2018
Study CompletionJul 27, 2018
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 11.0 years ago
Interventions
Observationalother